Targeting Bacterial Topoisomerase I to Meet the Challenge of Finding New Antibiotics

References

• Carlet J , PulciniC, PiddockLJ. Antibiotic resistance: a geo-political issue. Clin. MicroBiol. Infect.20 (10), 949–953 (2014).
   PubMed Web of Science ®Google Scholar
• Gunther G . Multidrug-resistant and extensively drug-resistant tuberculosis: a review of current concepts and future challenges. Clin. Med.14 (3), 279–285 (2014).
   PubMed Web of Science ®Google Scholar
• Bodro M , SabeN, TubauFet al. Extensively drug-resistant Pseudomonas aeruginosa bacteremia in solid organ transplant recipients. Transplantation99 (3), 616–622 (2014).
   Web of Science ®Google Scholar
• Hischebeth GT , WimmerMD, MolitorE, SeifertH, GraviusS, Bekeredjian-DingI. Multidrug resistant Acinetobacter baumannii reaches a new frontier: prosthetic hip joint infection. Infection (2014) (doi: 10.1007/s15010-014-0661-x).
   PubMedGoogle Scholar
• Gardete S , TomaszA. Mechanisms of vancomycin resistance in Staphylococcus aureus. J. Clin. Invest.124 (7), 2836–2840 (2014).
   PubMed Web of Science ®Google Scholar
• Boucher HW , TalbotGH, BradleyJSet al. Bad bugs, no drugs: no ESKAPE! An update from the Infectious Diseases Society of America. Clin. Infect. Dis.48 (1), 1–12 (2009).
   PubMed Web of Science ®Google Scholar
• Bassetti M , MerelliM, TemperoniC, AstileanA. New antibiotics for bad bugs: where are we?Ann. Clin. MicroBiol. Antimicrob.12, 22–0711–0712–22 (2013).
   PubMed Web of Science ®Google Scholar
• Forterre P , GadelleD. Phylogenomics of DNA topoisomerases: their origin and putative roles in the emergence of modern organisms. Nucleic Acids Res.37 (3), 679–692 (2009).
   PubMed Web of Science ®Google Scholar
• Tse YC , KirkegaardK, WangJC. Covalent bonds between protein and DNA. Formation of phosphotyrosine linkage between certain DNA topoisomerases and DNA. J. Biol. Chem.255 (12), 5560–5565 (1980).
   PubMed Web of Science ®Google Scholar
• Wang JC . Cellular roles of DNA topoisomerases: a molecular perspective. Nat. Rev. Mol. Cell Biol.3 (6), 430–440 (2002).
   PubMed Web of Science ®Google Scholar
• Chen SH , ChanNL, HsiehTS. New mechanistic and functional insights into DNA topoisomerases. Annu. Rev. BioChem.82, 139–170 (2013).
   PubMed Web of Science ®Google Scholar
• Aldred KJ , KernsRJ, OsheroffN. Mechanism of quinolone action and resistance. Biochemistry53 (10), 1565–1574 (2014).
   PubMed Web of Science ®Google Scholar
• Mitscher LA . Bacterial topoisomerase inhibitors: quinolone and pyridone antibacterial agents. Chem. Rev.105 (2), 559–592 (2005).
   PubMed Web of Science ®Google Scholar
• Mayer C , JaninYL. Non-quinolone inhibitors of bacterial type IIA topoisomerases: a feat of bioisosterism. Chem. Rev.114 (4), 2313–2342 (2014).
   PubMed Web of Science ®Google Scholar
• Pommier Y . Drugging topoisomerases: lessons and challenges. ACS Chem. Biol.8 (1), 82–95 (2013).
   PubMed Web of Science ®Google Scholar
• Aedo S , Tse-DinhYC. Isolation and quantitation of topoisomerase complexes accumulated on Escherichia coli chromosomal DNA. Antimicrob. Agents Chemother.56 (11), 5458–5464 (2012).
   PubMed Web of Science ®Google Scholar
• Pommier Y , LeoE, ZhangH, MarchandC. DNA topoisomerases and their poisoning by anticancer and antibacterial drugs. Chem. Biol.17 (5), 421–433 (2010).
   PubMed Web of Science ®Google Scholar
• Cheng B , ShuklaS, VasunilashornS, MukhopadhyayS, Tse-DinhYC. Bacterial cell killing mediated by topoisomerase I DNA cleavage activity. J. Biol. Chem.280 (46), 38489–38495 (2005).
   PubMed Web of Science ®Google Scholar
• Tse-Dinh YC . Bacterial topoisomerase I as a target for discovery of antibacterial compounds. Nucleic Acids Res.37 (3), 731–737 (2009).
   PubMed Web of Science ®Google Scholar
• Cheng B , AnnamalaiT, SorokinE, AbrenicaM, AedoS, Tse-DinhYC. Asp-to-Asn substitution at the first position of the DxD TOPRIM motif of recombinant bacterial topoisomerase I is extremely lethal to E. coli. J. Mol. Biol.385 (2), 558–567 (2009).
   PubMed Web of Science ®Google Scholar
• Narula G , AnnamalaiT, AedoSet al. The strictly conserved Arg-321 residue in the active site of Escherichia coli topoisomerase I plays a critical role in DNA rejoining. J. Biol. Chem.286 (21), 18673–18680 (2011).
   PubMed Web of Science ®Google Scholar
• Sutherland JH , Tse-DinhYC. Analysis of RuvABC and RecG involvement in the Escherichia coli response to the covalent topoisomerase–DNA complex. J. Bacteriol.192 (17), 4445–4451 (2010).
   PubMed Web of Science ®Google Scholar
• Sutherland JH , ChengB, LiuIF, Tse-DinhYC. SOS induction by stabilized topoisomerase IA cleavage complex occurs via the RecBCD pathway. J. Bacteriol.190 (9), 3399–3403 (2008).
   PubMed Web of Science ®Google Scholar
• Connelly JC , de LeauES, LeachDR. Nucleolytic processing of a protein-bound DNA end by the E. coli SbcCD (MR) complex. DNA Repair (Amst.)2 (7), 795–807 (2003).
   PubMed Web of Science ®Google Scholar
• Aedo S , Tse-DinhYC. SbcCD-mediated processing of covalent gyrase–DNA complex in Escherichia coli. Antimicrob. Agents Chemother.57 (10), 5116–5119 (2013).
   PubMed Web of Science ®Google Scholar
• Hartsuiker E , NealeMJ, CarrAM. Distinct requirements for the Rad32(Mre11) nuclease and Ctp1(CtIP) in the removal of covalently bound topoisomerase I and II from DNA. Mol. Cell33 (1), 117–123 (2009).
   PubMed Web of Science ®Google Scholar
• Pouliot JJ , YaoKC, RobertsonCA, NashHA. Yeast gene for a Tyr-DNA phosphodiesterase that repairs topoisomerase I complexes. Science286 (5439), 552–555 (1999).
   PubMed Web of Science ®Google Scholar
• Ledesma FC , El KhamisySF, ZumaMC, OsbornK, CaldecottKW. A human 5′-tyrosyl DNA phosphodiesterase that repairs topoisomerase-mediated DNA damage. Nature461 (7264), 674–678 (2009).
   PubMed Web of Science ®Google Scholar
• Marchand C , HuangSY, DexheimerTSet al. Biochemical assays for the discovery of TDP1 inhibitors. Mol. Cancer Ther.13 (8), 2116–2126 (2014).
   PubMed Web of Science ®Google Scholar
• Raoof A , DepledgeP, HamiltonNMet al. Toxoflavins and deazaflavins as the first reported selective small molecule inhibitors of tyrosyl-DNA phosphodiesterase II. J. Med. Chem.56 (16), 6352–6370 (2013).
   PubMed Web of Science ®Google Scholar
• Vos SM , TretterEM, SchmidtBH, BergerJM. All tangled up: how cells direct, manage and exploit topoisomerase function. Nat. Rev. Mol. Cell Biol.12 (12), 827–841 (2011).
   PubMed Web of Science ®Google Scholar
• Tse-Dinh YC . Increased sensitivity to oxidative challenges associated with topA deletion in Escherichia coli. J. Bacteriol.182 (3), 829–832 (2000).
   PubMed Web of Science ®Google Scholar
• Qi H , MenzelR, Tse-DinhYC. Increased thermosensitivity associated with topoisomerase I deletion and promoter mutations in Escherichia coli. FEMS MicroBiol. Lett.178 (1), 141–146 (1999).
   PubMed Web of Science ®Google Scholar
• Liu IF , SutherlandJH, ChengB, Tse-DinhYC. Topoisomerase I function during Escherichia coli response to antibiotics and stress enhances cell killing from stabilization of its cleavage complex. J. Antimicrob. Chemother.66 (7), 1518–1524 (2011).
   PubMed Web of Science ®Google Scholar
• Liu LF , WangJC. Supercoiling of the DNA template during transcription. Proc. Natl Acad. Sci. USA84 (20), 7024–7027 (1987).
   PubMed Web of Science ®Google Scholar
• Cheng B , RuiS, JiCet al. RNase H overproduction allows the expression of stress-induced genes in the absence of topoisomerase I. FEMS MicroBiol. Lett.221 (2), 237–242 (2003).
   PubMed Web of Science ®Google Scholar
• Usongo V , TanguayC, NolentF, BessongJE, DroletM. Interplay between type 1A topoisomerases and gyrase in chromosome segregation in Escherichia coli. J. Bacteriol.195 (8), 1758–1768 (2013).
   PubMed Web of Science ®Google Scholar
• Usongo V , DroletM. Roles of Type 1A topoisomerases in genome maintenance in Escherichia coli. PLoS Genet.10 (8), e1004543 (2014).
   PubMed Web of Science ®Google Scholar
• Terekhova K , MarkoJF, MondragonA. Studies of bacterial topoisomerases I and III at the single-molecule level. BioChem. Soc. Trans.41 (2), 571–575 (2013).
   PubMedGoogle Scholar
• Suerbaum S , Brauer-SteppkesT, LabigneA, CameronB, DrlicaK. Topoisomerase I of Helicobacter pylori: juxtaposition with a flagellin gene (flaB) and functional requirement of a fourth zinc finger motif. Gene210 (1), 151–161 (1998).
   PubMed Web of Science ®Google Scholar
• Dong Q , HydeD, HerraCet al. Identification of genes regulated by prolonged acid exposure in Helicobacter pylori. FEMS MicroBiol. Lett.196 (2), 245–249 (2001).
   PubMed Web of Science ®Google Scholar
• Tessier MC , GravelineR, CrostCet al. Effects of DNA supercoiling and topoisomerases on the expression of genes coding for F165(1), a P-like fimbriae. FEMS MicroBiol. Lett.277 (1), 28–36 (2007).
   PubMed Web of Science ®Google Scholar
• Vanga BR , ButlerRC, TothIK, RonsonCW, PitmanAR. Inactivation of PbTopo III beta causes hyper-excision of the Pathogenicity Island HAI2 resulting in reduced virulence of Pectobacterium atrosepticum. Mol. MicroBiol.84 (4), 648–663 (2012).
   PubMed Web of Science ®Google Scholar
• Koehler TM . Bacillus anthracis physiology and genetics. Mol. Aspects Med.30 (6), 386–396 (2009).
   PubMed Web of Science ®Google Scholar
• Head NE , YuH. Cross-sectional analysis of clinical and environmental isolates of Pseudomonas aeruginosa: biofilm formation, virulence, and genome diversity. Infect. Immun.72 (1), 133–144 (2004).
   PubMed Web of Science ®Google Scholar
• Ahmed W , MenonS, GodboleAA, KarthikPV, NagarajaV. Conditional silencing of topoisomerase I gene of Mycobacterium tuberculosis validates its essentiality for cell survival. FEMS MicroBiol. Lett.353 (2), 116–123 (2014).
   PubMed Web of Science ®Google Scholar
• Szafran M , SkutP, DitkowskiBet al. Topoisomerase I (TopA) is recruited to ParB complexes and is required for proper chromosome organization during Streptomyces coelicolor sporulation. J. Bacteriol.195 (19), 4445–4455 (2013).
   PubMed Web of Science ®Google Scholar
• Harmon FG , DiGateRJ, KowalczykowskiSC. RecQ helicase and topoisomerase III comprise a novel DNA strand passage function: a conserved mechanism for control of DNA recombination. Mol. Cell3 (5), 611–620 (1999).
   PubMed Web of Science ®Google Scholar
• Xu D , ShenW, GuoRet al. Top3beta is an RNA topoisomerase that works with fragile X syndrome protein to promote synapse formation. Nat. Neurosci.16 (9), 1238–1247 (2013).
   PubMed Web of Science ®Google Scholar
• Stoll G , PietilainenOP, LinderBet al. Deletion of TOP3beta, a component of FMRP-containing mRNPs, contributes to neurodevelopmental disorders. Nat. Neurosci.16 (9), 1228–1237 (2013).
   PubMed Web of Science ®Google Scholar
• Wang H , Di GateRJ, SeemanNC. An RNA topoisomerase. Proc. Natl Acad. Sci. USA93 (18), 9477–9482 (1996).
   PubMed Web of Science ®Google Scholar
• Phillips I , CulebrasE, MorenoF, BaqueroF. Induction of the SOS response by new 4-quinolones. J. Antimicrob. Chemother.20 (5), 631–638 (1987).
   PubMed Web of Science ®Google Scholar
• Cheng B , LiuI, Tse-DinhYC. Compounds with antibacterial activity that enhance DNA cleavage by bacterial DNA topoisomerase I. J. Antimicrob. Chemother.59, 640–645 (2007).
   PubMed Web of Science ®Google Scholar
• Van Dyk TK , WeiY, HanafeyMKet al. A genomic approach to gene fusion technology. Proc. Natl Acad. Sci. USA98 (5), 2555–2560 (2001).
   PubMed Web of Science ®Google Scholar
• Tang SC , ShapiroTA. Newly identified antibacterial compounds are topoisomerase poisons in African trypanosomes. Antimicrob. Agents Chemother.54 (2), 620–626 (2010).
   PubMed Web of Science ®Google Scholar
• Zechiedrich EL , KhodurskyAB, BachellierSet al. Roles of topoisomerases in maintaining steady-state DNA supercoiling in Escherichia coli. J. Biol. Chem.275 (11), 8103–8113 (2000).
   PubMed Web of Science ®Google Scholar
• Menzel R , GellertM. Regulation of the genes for E. coli DNA gyrase: homeostatic control of DNA supercoiling. Cell34 (1), 105–113 (1983).
   PubMed Web of Science ®Google Scholar
• Tse-Dinh YC . Regulation of the Escherichia coli DNA topoisomerase I gene by DNA supercoiling. Nucleic Acids Res.13 (13), 4751–4763 (1985).
   PubMed Web of Science ®Google Scholar
• Abu Mraheil M , HeisigA, HeisigP. An improved assay for the detection of alterations in bacterial DNA supercoiling in vivo. Pharmazie68 (7), 541–548 (2013).
   PubMed Web of Science ®Google Scholar
• Shapiro A , JahicH, PrasadSet al. A homogeneous, high-throughput fluorescence anisotropy-based DNA supercoiling assay. J. Biomol. Screen.15 (9), 1088–1098 (2010).
   PubMedGoogle Scholar
• Maxwell A , BurtonNP, O'HaganN. High-throughput assays for DNA gyrase and other topoisomerases. Nucleic Acids Res.34 (15), e104 (2006).
   PubMed Web of Science ®Google Scholar
• Burrell MR , BurtonNP, MaxwellA. A high-throughput assay for DNA topoisomerases and other enzymes, based on DNA triplex formation. Methods Mol. Biol.613, 257–266 (2010).
   PubMedGoogle Scholar
• Lilley DM . The inverted repeat as a recognizable structural feature in supercoiled DNA molecules. Proc. Natl Acad. Sci. USA77 (11), 6468–6472 (1980).
   PubMed Web of Science ®Google Scholar
• Jude KM , HartlandA, BergerJM. Real-time detection of DNA topological changes with a fluorescently labeled cruciform. Nucleic Acids Res.41 (13), e133 (2013).
   PubMed Web of Science ®Google Scholar
• Domagala JM , HannaLD, HeifetzCLet al. New structure–activity relationships of the quinolone antibacterials using the target enzyme. The development and application of a DNA gyrase assay. J. Med. Chem.29 (3), 394–404 (1986).
   PubMed Web of Science ®Google Scholar
• Walton L , ElwellLP. In vitro cleavable-complex assay to monitor antimicrobial potency of quinolones. Antimicrob. Agents Chemother.32 (7), 1086–1089 (1988).
   PubMed Web of Science ®Google Scholar
• Cheng B , CaoS, VasquezVet al. Identification of anziaic acid, a lichen depside from Hypotrachyna sp., as a new topoisomerase poison inhibitor. PLoS ONE8 (4), e60770 (2013).
   PubMed Web of Science ®Google Scholar
• PubChem BioAssay. ==https://pubchem.ncbi.nlm.nih.gov/assay/assaydata.html?aid=504884&act=act
   Google Scholar
• Garcia MT , BlazquezMA, FerrandizMJet al. New alkaloid antibiotics that target the DNA topoisomerase I of Streptococcus pneumoniae. J. Biol. Chem.286 (8), 6402–6413 (2010).
   PubMed Web of Science ®Google Scholar
• Bansal S , SinhaD, SinghM, ChengB, Tse-DinhYC, TandonV. 3,4-Dimethoxyphenyl bis-benzimidazole, a novel DNA topoisomerase inhibitor that preferentially targets Escherichia coli topoisomerase I. J. Antimicrob. Chemother.67 (12), 2882–2891 (2012).
   PubMed Web of Science ®Google Scholar
• Bansal S , TawarU, SinghM, NikraveshA, GoodL, TandonV. Old class but new dimethoxy analogue of benzimidazole: a bacterial topoisomerase I inhibitor. Int. J. Antimicrob. Agents.35 (2), 186–190 (2010).
   PubMed Web of Science ®Google Scholar
• Ranjan N , FulcrandG, KingAet al. Selective inhibition of bacterial topoisomerase I by alkynyl-bisbenzimidazoles. Medchemcomm5 (6), 816–825 (2014).
   PubMed Web of Science ®Google Scholar
• Nimesh H , SurS, SinhaDet al. Synthesis and biological evaluation of novel bisbenzimidazoles as Escherichia coli topoisomerase IA inhibitors and potential antibacterial agents. J. Med. Chem.57 (12), 5238–5257 (2014).
   PubMed Web of Science ®Google Scholar
• Duan F , LiX, CaiSet al. Haloemodin as novel antibacterial agent inhibiting DNA gyrase and bacterial topoisomerase I. J. Med. Chem.57 (9), 3707–3714 (2014).
   PubMed Web of Science ®Google Scholar
• Ferrandiz MJ , de la CampaAG. The fluoroquinolone levofloxacin triggers the transcriptional activation of iron transport genes that contribute to cell death in Streptococcus pneumoniae. Antimicrob. Agents Chemother.58 (1), 247–257 (2014).
   PubMed Web of Science ®Google Scholar
• Chen AY , YuC, GattoB, LiuLF. DNA minor groove-binding ligands: a different class of mammalian DNA topoisomerase I inhibitors. Proc. Natl Acad. Sci. USA90 (17), 8131–8135 (1993).
   PubMed Web of Science ®Google Scholar
• Braun M , SilhavyTJ. Imp/OstA is required for cell envelope biogenesis in Escherichia coli. Mol. Microbiol.45 (5), 1289–1302 (2002).
   PubMed Web of Science ®Google Scholar
• Lin H , AnnamalaiT, BansodP, Tse-DinhYC, SunD. Synthesis and antibacterial evaluation of anziaic acid and analogues as topoisomerase I inhibitors. Medchemcomm4 (12), doi:10.1039/C3MD00238A (2013) ( Epub ahead of print).
   Web of Science ®Google Scholar
• Tari LW , LiX, TrzossMet al. Tricyclic GyrB/ParE (TriBE) inhibitors: a new class of broad-spectrum dual-targeting antibacterial agents. PLoS ONE8 (12), e84409 (2013).
   PubMed Web of Science ®Google Scholar
• Berger JM , FassD, WangJC, HarrisonSC. Structural similarities between topoisomerases that cleave one or both DNA strands. Proc. Natl Acad. Sci. USA95 (14), 7876–7881 (1998).
   PubMed Web of Science ®Google Scholar
• Schmidt BH , BurginAB, DeweeseJE, OsheroffN, BergerJM. A novel and unified two-metal mechanism for DNA cleavage by type II and IA topoisomerases. Nature465 (7298), 641–644 (2010).
   PubMed Web of Science ®Google Scholar
• Godbole AA , AhmedW, BhatRS, BradleyEK, EkinsS, NagarajaV. Inhibition of Mycobacterium tuberculosis topoisomerase I by m-AMSA, a eukaryotic type II topoisomerase poison. BioChem. Biophys. Res. Commun.446 (4), 916–920 (2014).
   PubMed Web of Science ®Google Scholar
• Taylor JA , MitchenallLA, RejzekM, FieldRA, MaxwellA. Application of a novel microtitre plate-based assay for the discovery of new inhibitors of DNA gyrase and DNA topoisomerase VI. PLoS ONE8 (2), e58010 (2013).
   PubMed Web of Science ®Google Scholar
• Casu L , CottigliaF, LeontiMet al. Ungeremine effectively targets mammalian as well as bacterial type I and type II topoisomerases. Bioorg. Med. Chem. Lett.21 (23), 7041–7044 (2011).
   PubMed Web of Science ®Google Scholar
• Huang F , HeZG. Characterization of an interplay between a Mycobacterium tuberculosis MazF homolog, Rv1495 and its sole DNA topoisomerase I. Nucleic Acids Res.38 (22), 8219–8230 (2010).
   PubMed Web of Science ®Google Scholar
• Leelaram MN , BhatAG, HegdeSM, ManjunathR, NagarajaV. Inhibition of type IA topoisomerase by a monoclonal antibody through perturbation of DNA cleavage–religation equilibrium. FEBS J.279 (1), 55–65 (2012).
   PubMed Web of Science ®Google Scholar
• Leelaram MN , BhatAG, GodboleAA, BhatRS, ManjunathR, NagarajaV. Type IA topoisomerase inhibition by clamp closure. FASEB J.27 (8), 3030–3038 (2013).
   PubMed Web of Science ®Google Scholar
• Bocquet N , BizardAH, AbdulrahmanWet al. Structural and mechanistic insight into Holliday-junction dissolution by topoisomerase III alpha and RMI1. Nat. Struct. Mol. Biol.21 (3), 261–268 (2014).
   PubMed Web of Science ®Google Scholar
• Ahmed W , BhatAG, LeelaramMN, MenonS, NagarajaV. Carboxyl terminal domain basic amino acids of mycobacterial topoisomerase I bind DNA to promote strand passage. Nucleic Acids Res.41 (15), 7462–7471 (2013).
   PubMed Web of Science ®Google Scholar
• Szafran MJ , StrickT, StrzalkaA, Zakrzewska-CzerwinskaJ, JakimowiczD. A highly processive topoisomerase I: studies at the single-molecule level. Nucleic Acids Res.42 (12), 7935–7946 (2014).
   PubMed Web of Science ®Google Scholar